Prednisone Delayed Release Tablet, Delayed Release
NDC Package 74157-019-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Prednisone Delayed Release (prednisone) tablets is prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. This formulation utilizes a tablet, delayed release delivery system. Marketed by Ina Pharmaceutics Inc, this product is identified by NDC 74157-019 and is authorized under FDA application ANDA219477.

Identification & Billing

NDC Package Code
74157-019-30
Package Description
1 BOTTLE in 1 CARTON / 30 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code
74157-019
11-Digit Billing Format
74157001930
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Prednisone Delayed Release
Non-Proprietary Name
Prednisone
Substance Name
Prednisone
Dosage Form
Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PREDNISONE 2 mg/1
Pharmacologic Class
Usage Information
Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Regulatory & Marketing

Labeler Name
Ina Pharmaceutics Inc
Product Type
Human Prescription Drug
FDA Application #
ANDA219477
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 74157-019-30 identifies a specific commercial package of 1 bottle in 1 carton / 30 tablet, delayed release in 1 bottle of Prednisone Delayed Release, a human prescription drug labeled by Ina Pharmaceutics Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet, delayed release is formulated for oral use and contains prednisone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ina Pharmaceutics Inc on December 15, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

How is this Ina Pharmaceutics Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 74157001930. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
74157-019-30
11-Digit CMS (5-4-2)
74157-0019-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.